Passot G - Search Results

1

Advances in the management of peritoneal malignancies.

Kepenekian V, Bhatt A, Péron J, Alyami M, Benzerdjeb N, Bakrin N, Falandry C, Passot G, Rousset P, Glehen O. Kepenekian V, et al. Among authors: passot g. Nat Rev Clin Oncol. 2022 Nov;19(11):698-718. doi: 10.1038/s41571-022-00675-5. Epub 2022 Sep 7. Nat Rev Clin Oncol. 2022. PMID: 36071285 Review.

2

Hyperthermic intraperitoneal chemotherapy: nomenclature and modalities of perfusion.

Glehen O, Cotte E, Kusamura S, Deraco M, Baratti D, Passot G, Beaujard AC, Noel GF. Glehen O, et al. Among authors: passot g. J Surg Oncol. 2008 Sep 15;98(4):242-6. doi: 10.1002/jso.21061. J Surg Oncol. 2008. PMID: 18726885 Review.

3

[Malignant primary peritoneal tumors].

Cotte E, Passot G, Isaac S, Gilly FN, Glehen O. Cotte E, et al. Among authors: passot g. Presse Med. 2009 Dec;38(12):1814-22. doi: 10.1016/j.lpm.2008.10.025. Epub 2009 Apr 7. Presse Med. 2009. PMID: 19356892 Review. French.

4

Management of peritoneal carcinomatosis from colorectal cancer: current state of practice.

Cotte E, Passot G, Mohamed F, Vaudoyer D, Gilly FN, Glehen O. Cotte E, et al. Among authors: passot g. Cancer J. 2009 May-Jun;15(3):243-8. doi: 10.1097/PPO.0b013e3181a58d67. Cancer J. 2009. PMID: 19556911 Review.

5

Selection of patients and staging of peritoneal surface malignancies.

Cotte E, Passot G, Gilly FN, Glehen O. Cotte E, et al. Among authors: passot g. World J Gastrointest Oncol. 2010 Jan 15;2(1):31-5. doi: 10.4251/wjgo.v2.i1.31. World J Gastrointest Oncol. 2010. PMID: 21160814 Free PMC article.

6

Closed abdomen hyperthermic intraperitoneal chemotherapy with irinotecan and mitomycin C: a phase I study.

Cotte E, Passot G, Tod M, Bakrin N, Gilly FN, Steghens A, Mohamed F, Glehen O. Cotte E, et al. Among authors: passot g. Ann Surg Oncol. 2011 Sep;18(9):2599-603. doi: 10.1245/s10434-011-1651-1. Epub 2011 Mar 19. Ann Surg Oncol. 2011. PMID: 21424369 Clinical Trial.

7

Peritoneal carcinomatosis from appendiceal cancer: early adequate therapeutic management for long-term survival.

Glehen O, Bakrin N, Passot G. Glehen O, et al. Among authors: passot g. Ann Surg Oncol. 2011 Jun;18(6):1522-3. doi: 10.1245/s10434-011-1718-z. Ann Surg Oncol. 2011. PMID: 21487964 No abstract available.

8

Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: postoperative and long-term results.

Golse N, Bakrin N, Passot G, Mohamed F, Vaudoyer D, Gilly FN, Glehen O, Cotte E. Golse N, et al. Among authors: passot g. J Surg Oncol. 2012 Aug 1;106(2):197-203. doi: 10.1002/jso.23062. Epub 2012 Feb 13. J Surg Oncol. 2012. PMID: 22331814

9

Progression following neoadjuvant systemic chemotherapy may not be a contraindication to a curative approach for colorectal carcinomatosis.

Passot G, Vaudoyer D, Cotte E, You B, Isaac S, Noël Gilly F, Mohamed F, Glehen O. Passot G, et al. Ann Surg. 2012 Jul;256(1):125-9. doi: 10.1097/SLA.0b013e318255486a. Ann Surg. 2012. PMID: 22580942

10

Intraperitoneal bevacizumab combined with cytoreductive surgery: a pre-clinical study of tolerance and pharmacokinetics in an animal model.

Passot G, Dupré A, Rivoire M, Mohamed F, Bakrin N, Glehen O. Passot G, et al. Clin Transl Oncol. 2012 Dec;14(12):931-6. doi: 10.1007/s12094-012-0888-x. Epub 2012 Jul 24. Clin Transl Oncol. 2012. PMID: 22855172

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

226 results

Search Page